<!DOCTYPE html> <html lang="en"> <head> <meta http-equiv="Content-Type" content="text/html; charset=UTF-8"> <meta name="google-site-verification" content="Pj4WWF5m9cqCcPqkGG75BI1_593zXImuFRpI8TnAous"> <meta http-equiv="Permissions-Policy" content="interest-cohort=()"> <meta charset="utf-8"> <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <title> The Unsung Roles of HTLV-1 in the Discovery of CD25 and Treg | Masahiro Ono </title> <meta name="author" content="Masahiro Ono"> <meta name="description" content="How CD25 and Treg were discovered through HTLV-1"> <meta name="keywords" content="jekyll, jekyll-theme, academic-website, portfolio-website"> <meta property="og:site_name" content="Masahiro Ono"> <meta property="og:type" content="article"> <meta property="og:title" content="Masahiro Ono | The Unsung Roles of HTLV-1 in the Discovery of CD25 and Treg"> <meta property="og:url" content="https://monotockylab.github.io/blog/2024/CD25/"> <meta property="og:description" content="How CD25 and Treg were discovered through HTLV-1"> <meta property="og:image" content="https://monotockylab.github.io/assets/img/MonoTockyLab.png"> <meta property="og:image:url" content="https://monotockylab.github.io/assets/img/MonoTockyLab.png"> <meta property="og:image:secure_url" content="https://monotockylab.github.io/assets/img/MonoTockyLab.png"> <meta property="og:locale" content="en"> <meta name="twitter:card" content="summary_large_image"> <meta name="twitter:site" content="@MonoTockyLab"> <meta name="twitter:creator" content="@MonoTockyLab"> <meta name="twitter:title" content="Masahiro Ono | The Unsung Roles of HTLV-1 in the Discovery of CD25 and Treg"> <meta name="twitter:description" content="How CD25 and Treg were discovered through HTLV-1"> <meta name="twitter:image" content="https://monotockylab.github.io/assets/img/MonoTockyLab.png"> <link rel="stylesheet" href="/assets/css/bootstrap.min.css?a4b3f509e79c54a512b890d73235ef04"> <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/css/mdb.min.css" integrity="sha256-jpjYvU3G3N6nrrBwXJoVEYI/0zw8htfFnhT9ljN3JJw=" crossorigin="anonymous"> <link defer rel="stylesheet" href="/assets/css/academicons.min.css?f0b7046b84e425c55f3463ac249818f5"> <link defer rel="stylesheet" type="text/css" href="https://fonts.googleapis.com/css?family=Roboto:300,400,500,700|Roboto+Slab:100,300,400,500,700|Material+Icons&amp;display=swap"> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-github.css?591dab5a4e56573bf4ef7fd332894c99" media="" id="highlight_theme_light"> <link rel="shortcut icon" href="/assets/img/favicon.png?fdf6bb598ff65151e77547fe2c57a41a"> <link rel="stylesheet" href="/assets/css/main.css?d41d8cd98f00b204e9800998ecf8427e"> <link rel="canonical" href="https://monotockylab.github.io/blog/2024/CD25/"> <script src="/assets/js/theme.js?a5ca4084d3b81624bcfa01156dae2b8e"></script> <link defer rel="stylesheet" href="/assets/css/jekyll-pygments-themes-native.css?5847e5ed4a4568527aa6cfab446049ca" media="none" id="highlight_theme_dark"> <script>initTheme();</script> <link defer rel="stylesheet" href="https://cdn.jsdelivr.net/npm/img-comparison-slider@8.0.6/dist/styles.min.css"> <link defer rel="stylesheet" href="https://cdn.jsdelivr.net/npm/swiper@11.0.5/swiper-bundle.min.css" integrity="sha256-yUoNxsvX+Vo8Trj3lZ/Y5ZBf8HlBFsB6Xwm7rH75/9E=" crossorigin="anonymous"> </head> <body class="fixed-top-nav "> <header> <nav id="navbar" class="navbar navbar-light navbar-expand-sm fixed-top" role="navigation"> <div class="container"> <a class="navbar-brand title font-weight-lighter" href="/"> Masahiro Ono </a> <button class="navbar-toggler collapsed ml-auto" type="button" data-toggle="collapse" data-target="#navbarNav" aria-controls="navbarNav" aria-expanded="false" aria-label="Toggle navigation"> <span class="sr-only">Toggle navigation</span> <span class="icon-bar top-bar"></span> <span class="icon-bar middle-bar"></span> <span class="icon-bar bottom-bar"></span> </button> <div class="collapse navbar-collapse text-right" id="navbarNav"> <ul class="navbar-nav ml-auto flex-nowrap"> <li class="nav-item "> <a class="nav-link" href="/">about </a> </li> <li class="nav-item "> <a class="nav-link" href="/blog/">blog </a> </li> <li class="nav-item "> <a class="nav-link" href="/publications/">publications </a> </li> <li class="nav-item "> <a class="nav-link" href="/research/">research </a> </li> <li class="nav-item "> <a class="nav-link" href="/tocky/">Tocky </a> </li> <li class="nav-item "> <a class="nav-link" href="/cv/">cv </a> </li> <li class="nav-item "> <a class="nav-link" href="/researcher/">researcher </a> </li> <li class="nav-item dropdown "> <a class="nav-link dropdown-toggle" href="#" id="navbarDropdown" role="button" data-toggle="dropdown" aria-haspopup="true" aria-expanded="false">submenus </a> <div class="dropdown-menu dropdown-menu-right" aria-labelledby="navbarDropdown"> <a class="dropdown-item " href="/talks/">talks</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/research/">research</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/japanese/">日本語</a> <div class="dropdown-divider"></div> <a class="dropdown-item " href="/access/">access</a> </div> </li> <li class="toggle-container"> <button id="light-toggle" title="Change theme"> <i class="ti ti-sun-moon" id="light-toggle-system"></i> <i class="ti ti-moon-filled" id="light-toggle-dark"></i> <i class="ti ti-sun-filled" id="light-toggle-light"></i> </button> </li> </ul> </div> </div> </nav> <progress id="progress" value="0"> <div class="progress-container"> <span class="progress-bar"></span> </div> </progress> </header> <div class="container mt-5" role="main"> <div class="post"> <header class="post-header"> <h1 class="post-title">The Unsung Roles of HTLV-1 in the Discovery of CD25 and Treg</h1> <p class="post-meta"> June 21, 2024 </p> <p class="post-tags"> <a href="/blog/2024"> <i class="fa-solid fa-calendar fa-sm"></i> 2024 </a>   ·   <a href="/blog/tag/cd25"> <i class="fa-solid fa-hashtag fa-sm"></i> CD25</a>   <a href="/blog/tag/htlv-1"> <i class="fa-solid fa-hashtag fa-sm"></i> HTLV-1</a>   <a href="/blog/tag/atl"> <i class="fa-solid fa-hashtag fa-sm"></i> ATL</a>   <a href="/blog/tag/treg"> <i class="fa-solid fa-hashtag fa-sm"></i> Treg</a>     ·   <a href="/blog/category/blog"> <i class="fa-solid fa-tag fa-sm"></i> blog</a>   </p> </header> <article class="post-content"> <div id="markdown-content"> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/tocky/cd4foxp3-480.webp 480w,/assets/img/tocky/cd4foxp3-800.webp 800w,/assets/img/tocky/cd4foxp3-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/tocky/cd4foxp3.jpg" class="img-fluid rounded z-depth-1" width="400" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <div class="caption" style="text-align: center;"> CD4+ T cells (Green). Some express Foxp3 (Red) as well. Nucleus is stained by DAPI (blue). Credit Masahiro Ono. </div> <hr> <h4 id="the-leukaemia-inducing-retrovirus">The Leukaemia-Inducing Retrovirus</h4> <p>Human T-cell Leukemia Virus Type 1 (HTLV-1) affects certain regions worldwide, such as South Japan, the Caribbean, and parts of Africa. This virus, sharing infection routes similar to HIV, targets CD4+ T cells. Unlike HIV, HTLV-1 does not cause these cells to die off or diminish in number. Instead, in some individuals, it transforms these cells, leading to a rare and severe form of leukemia known as Adult T-cell leukemia/lymphoma (ATL). Others may develop a type of neuroinflammation known as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP).</p> <p>Research into HTLV-1 and ATL has played a crucial role in the discovery of regulatory T cells (Tregs), although this contribution is currently underappreciated. In this article, I aim to detail some of the historical developments where HTLV-1 studies not only preceded but also facilitated the discovery of CD25, leading to the discovery of Treg.</p> <hr> <h4 id="development-of-anti-cd25-antibody-using-cells-from-htlv-1-induced-leukemia">Development of Anti-CD25 Antibody Using Cells From HTLV-1-Induced Leukemia</h4> <p>One groundbreaking finding from ATL research was the cloning of the IL-2 receptor alpha chain gene, known as CD25. This discovery stemmed from the inability to culture ATL cells without high doses of IL-2, strongly suggesting these cells had high IL-2 receptor expression.</p> <p>Indeed, using ATL cells, researchers hypothesized this and created a specific monoclonal antibody, namely the <em>anti-Tac antibody</em>, which was produced by Dr Takashi Uchiyama. The clone name of the antibody was from Dr Uchiyama’s first name, Takashi.</p> <p><a href="https://link.springer.com/article/10.1007/s12185-010-0664-z" rel="external nofollow noopener" target="_blank">The obituary article</a> by Prof Kiyoshi Takatsuki, the discoverer of the ATL disease, details Dr Uchiyama’s work life and his dedication for ATL and administration in Kyoto University.</p> <p>In 1984, with Dr Uchiyama, the Nobel Laureate Prof Tasuku Honjo led the study to clone the previously unknown IL-2 receptor gene, which led to the successful cloning of the CD25 (Il2ra) gene <a href="https://doi.org/10.1038/311631a0" rel="external nofollow noopener" target="_blank">(Nikaido et al, 1984)</a>.</p> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/htlv/CD25-480.webp 480w,/assets/img/htlv/CD25-800.webp 800w,/assets/img/htlv/CD25-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/htlv/CD25.jpg" class="img-fluid rounded z-depth-1" width="800" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <div class="caption" style="text-align: center;"> Human IL2RA gene (CD25). </div> <hr> <h4 id="cloning-of-cd25-il2ra-il-2-receptor-alpha-chain">Cloning of CD25, IL2RA (IL-2 Receptor Alpha Chain)</h4> <p>Using the anti-Tac antibody and the cloned CD25 sequence, researchers revealed that any T cells express CD25 when activated; most ATL cells show constant high expression.</p> <p>This led to the creation of CD25 knockout mice. Researchers anticipated that the knockout mice would show severe immunosuppression as CD25 could not be used and T-cells would not be properly activated.</p> <p>However, surprisingly, the CD25 knockout mice developed autoimmune inflammation, rather than immunosuppression. This strongly suggests CD25’s role in immune regulation, rather than in the induction of T cell response.</p> <hr> <h4 id="the-discovery-of-cd25-tregs-in-the-90s-lost-opportunities-in-research-development">The Discovery of CD25+ Tregs in the 90s: Lost Opportunities in Research Development</h4> <p>The discovery of CD25 and the knockout phenotype spurred further investigations into CD25+ CD4+ T cells throughout the 90s. Key developments during this period laid the foundations of Treg research, determining the direction of subsequent studies.</p> <p>However, these studies in the 90s characterized Tregs as a ‘unique’ population of T-cells that physiologically develop during neonatal periods and failed to fully appreciate an important aspect of T-cell biology: cellular and molecular dynamics. This oversight was not due to technological limitations of the time but rather to specific unfortunate historical developments. These issues continue to impact the current research landscape. I will explore these critical issues in detail in the context of the discovery of CD25+ Tregs in my next article.</p> <hr> <h4 id="further-reading">Further Reading</h4> <p>For those interested in delving deeper into the link between CD25 and HTLV-1, please read our recent publication <a class="citation" href="#10.1093/discim/kyae006">(Ono &amp; Satou, 2024)</a>.</p> <hr> <h4 id="some-of-my-own-memories-for-htlv-1-and-the-anti-tac-antibody">Some of My Own Memories For HTLV-1 and the Anti-Tac Antibody</h4> <p>I had a fortunate medical education with more than half of the virology lectures dedicated to HTLV-1 and ATL; molecular biology lectures were mostly delivered by Prof Honjo.</p> <div class="row"> <div class="col-sm mt-3 mt-md-0 text-center"> <figure> <picture> <source class="responsive-img-srcset" srcset="/assets/img/htlv/Honjo-480.webp 480w,/assets/img/htlv/Honjo-800.webp 800w,/assets/img/htlv/Honjo-1400.webp 1400w," sizes="95vw" type="image/webp"></source> <img src="/assets/img/htlv/Honjo.jpg" class="img-fluid rounded z-depth-1" width="600" height="auto" data-zoomable="" loading="eager" onerror="this.onerror=null; $('.responsive-img-srcset').remove();"> </picture> </figure> </div> </div> <div class="caption" style="text-align: center;"> Prof Tasuku Honjo and Myself at European Congress of Immunology, 2018, in Amsterdam. </div> <p>Further, I was trained in dermatology in Kyoto University under the strong influence of Prof Uchiyama’s discoveries and achievements: the detection of elevated levels of soluble CD25 by anti-Tac antibody can help in the diagnosis and monitoring of ATL patients.</p> <hr> </div> </article> <h2>References</h2> <div class="publications"> <h2 class="bibliography">2024</h2> <ol class="bibliography"><li> <div class="row"> <div class="col-sm-2 abbr"> </div> <div id="10.1093/discim/kyae006" class="col-sm-8"> <div class="title">Spectrum of Treg and self-reactive T cells: single cell perspectives from old friend HTLV-1</div> <div class="author"> <em>Masahiro Ono</em>, and Yorifumi Satou </div> <div class="periodical"> <em>Discovery Immunology</em>, May 2024 </div> <div class="periodical"> <em style="color: darkgrey;"></em> </div> <div class="links"> <a class="abstract btn btn-sm z-depth-0" role="button">Abstract</a> <a href="https://doi.org/10.1093/discim/kyae006" class="btn btn-sm z-depth-0" role="button" rel="external nofollow noopener" target="_blank">Publication</a> </div> <div class="abstract hidden"> <p>Despite extensive regulatory T cell (Treg) research, fundamental questions on in vivo dynamics remain to be answered. The current study aims to dissect several interwoven concepts in Treg biology, highlighting the ‘self-reactivity’ of Treg and their counterparts, namely naturally-arising memory-phenotype T-cells, as a key mechanism to be exploited by a human retroviral infection. We propose the novel key concept, Periodic T cell receptor (TCR)-signalled T-cells, capturing self-reactivity in a quantifiable manner using the Nr4a3-Timer-of-cell-kinetics-and-activity (Tocky) technology. Periodic and brief TCR signals in self-reactive T-cells contrast with acute TCR signals during inflammation. Thus, we propose a new two-axis model for T-cell activation by the two types of TCR signals or antigen recognition, elucidating how Foxp3 expression and acute TCR signals actively regulate Periodic TCR-signalled T-cells. Next, we highlight an underappreciated branch of immunological research on Human T-cell Leukemia Virus type 1 (HTLV-1) that precedes Treg studies, illuminating the missing link between the viral infection, CD25, and Foxp3. Based on evidence by single-cell analysis, we show how the viral infection exploits the regulatory mechanisms for T-cell activation and suggests a potential role of periodic TCR signalling in infection and malignant transformation. In conclusion, the new perspectives and models in this study provide a working framework for investigating Treg within the self-reactive T-cell spectrum, expected to advance understanding of HTLV-1 infection, cancer, and immunotherapy strategies for these conditions.</p> </div> </div> </div> </li></ol> </div> <br> <hr> <br> <ul class="list-disc pl-8"></ul> <h2 class="text-3xl font-semibold mb-4 mt-12">Enjoy Reading This Article?</h2> <p class="mb-2">Here are some more articles you might like to read next:</p> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/TGN1412/">t-cell dynamics matter</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/CancerImmunotherapy/">tocky illuminates mechanisms of immune checkpoint blockade</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/dermatology/">professionalism and official account integrity</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/cca/">journey to tocky via cca</a> </li> <li class="my-2"> <a class="text-pink-700 underline font-semibold hover:text-pink-800" href="/blog/2024/timer/">timer and tocky</a> </li> </div> </div> <footer class="fixed-bottom" role="contentinfo"> <div class="container mt-0"> © Copyright 2024 Masahiro Ono. Powered by <a href="https://jekyllrb.com/" target="_blank" rel="external nofollow noopener">Jekyll</a> with <a href="https://github.com/alshedivat/al-folio" rel="external nofollow noopener" target="_blank">al-folio</a> theme. Hosted by <a href="https://pages.github.com/" target="_blank" rel="external nofollow noopener">GitHub Pages</a>. Last updated: November 24, 2024. </div> </footer> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.0/dist/jquery.min.js" integrity="sha256-/xUj+3OJU5yExlq6GSYGSHk7tPXikynS7ogEvDej/m4=" crossorigin="anonymous"></script> <script src="/assets/js/bootstrap.bundle.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/mdbootstrap@4.20.0/js/mdb.min.js" integrity="sha256-NdbiivsvWt7VYCt6hYNT3h/th9vSTL4EDWeGs5SN3DA=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/masonry-layout@4.2.2/dist/masonry.pkgd.min.js" integrity="sha256-Nn1q/fx0H7SNLZMQ5Hw5JLaTRZp0yILA/FRexe19VdI=" crossorigin="anonymous"></script> <script defer src="https://cdn.jsdelivr.net/npm/imagesloaded@5.0.0/imagesloaded.pkgd.min.js" integrity="sha256-htrLFfZJ6v5udOG+3kNLINIKh2gvoKqwEhHYfTTMICc=" crossorigin="anonymous"></script> <script defer src="/assets/js/masonry.js" type="text/javascript"></script> <script defer src="https://cdn.jsdelivr.net/npm/medium-zoom@1.1.0/dist/medium-zoom.min.js" integrity="sha256-ZgMyDAIYDYGxbcpJcfUnYwNevG/xi9OHKaR/8GK+jWc=" crossorigin="anonymous"></script> <script defer src="/assets/js/zoom.js?85ddb88934d28b74e78031fd54cf8308"></script> <script src="/assets/js/no_defer.js?5d75c11f89cd96294bf5e6dd1ee1bb30"></script> <script defer src="/assets/js/common.js?fcfacfb8c6281f5e68d5a7d348186eb1"></script> <script defer src="/assets/js/copy_code.js?12775fdf7f95e901d7119054556e495f" type="text/javascript"></script> <script defer src="/assets/js/jupyter_new_tab.js?d9f17b6adc2311cbabd747f4538bb15f"></script> <script async src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js"></script> <script async src="https://badge.dimensions.ai/badge.js"></script> <script type="text/javascript">window.MathJax={tex:{tags:"ams"}};</script> <script defer type="text/javascript" id="MathJax-script" src="https://cdn.jsdelivr.net/npm/mathjax@3.2.0/es5/tex-mml-chtml.js"></script> <script defer src="https://cdnjs.cloudflare.com/polyfill/v3/polyfill.min.js?features=es6"></script> <script async src="https://www.googletagmanager.com/gtag/js?id=G-VJHT0Y5RYF"></script> <script>function gtag(){window.dataLayer.push(arguments)}window.dataLayer=window.dataLayer||[],gtag("js",new Date),gtag("config","G-VJHT0Y5RYF");</script> <script type="text/javascript">function progressBarSetup(){"max"in document.createElement("progress")?(initializeProgressElement(),$(document).on("scroll",function(){progressBar.attr({value:getCurrentScrollPosition()})}),$(window).on("resize",initializeProgressElement)):(resizeProgressBar(),$(document).on("scroll",resizeProgressBar),$(window).on("resize",resizeProgressBar))}function getCurrentScrollPosition(){return $(window).scrollTop()}function initializeProgressElement(){let e=$("#navbar").outerHeight(!0);$("body").css({"padding-top":e}),$("progress-container").css({"padding-top":e}),progressBar.css({top:e}),progressBar.attr({max:getDistanceToScroll(),value:getCurrentScrollPosition()})}function getDistanceToScroll(){return $(document).height()-$(window).height()}function resizeProgressBar(){progressBar.css({width:getWidthPercentage()+"%"})}function getWidthPercentage(){return getCurrentScrollPosition()/getDistanceToScroll()*100}const progressBar=$("#progress");window.onload=function(){setTimeout(progressBarSetup,50)};</script> <script defer src="https://cdn.jsdelivr.net/npm/img-comparison-slider@8.0.6/dist/index.min.js"></script> <script defer src="https://cdn.jsdelivr.net/npm/swiper@11.0.5/swiper-element-bundle.min.js" integrity="sha256-BPrwikijIybg9OQC5SYFFqhBjERYOn97tCureFgYH1E=" crossorigin="anonymous"></script> </body> </html>